Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

NCT05432375 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Tinostamustine

Sponsor

Mundipharma Research Limited